BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11355915)

  • 21. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
    Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic therapy of Barrett's esophagus and esophageal adenocarcinoma.
    Tantau M; Mosteanu O; Pop T; Tantau A; Mester G
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):213-7. PubMed ID: 20593060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
    Foroulis CN; Thorpe JA
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current state of endoscopic therapies in Barrett's esophagus and esophageal cancer.
    Hudson M; Lin CL; Habr F
    Hosp Pract (1995); 2011 Feb; 39(1):170-80. PubMed ID: 21441773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
    Watson TJ
    Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technology insight: ablative techniques for Barrett's esophagus--current and emerging trends.
    Johnston MH
    Nat Clin Pract Oncol; 2005 Aug; 2(8):323-30. PubMed ID: 16130939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barrett's oesophagus--a pathologist's view.
    Fléjou JF; Svrcek M
    Histopathology; 2007 Jan; 50(1):3-14. PubMed ID: 17204017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
    Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus.
    Behrens A; May A; Gossner L; Günter E; Pech O; Vieth M; Stolte M; Seitz G; Ell C
    Endoscopy; 2005 Oct; 37(10):999-1005. PubMed ID: 16189774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic therapy of dysplasia and early-stage cancers of the esophagus.
    Tokar JL; Haluszka O; Weinberg DS
    Semin Radiat Oncol; 2007 Jan; 17(1):10-21. PubMed ID: 17185193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
    Morris CD; Byrne JP; Armstrong GR; Attwood SE
    Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
    Ganz RA; Overholt BF; Sharma VK; Fleischer DE; Shaheen NJ; Lightdale CJ; Freeman SR; Pruitt RE; Urayama SM; Gress F; Pavey DA; Branch MS; Savides TJ; Chang KJ; Muthusamy VR; Bohorfoush AG; Pace SC; DeMeester SR; Eysselein VE; Panjehpour M; Triadafilopoulos G;
    Gastrointest Endosc; 2008 Jul; 68(1):35-40. PubMed ID: 18355819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
    von Rahden BH; Feith M; Stein HJ
    Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-grade dysplasia in Barrett's oesophagus.
    Wright TA
    Br J Surg; 1997 Jun; 84(6):760-6. PubMed ID: 9189080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency ablation for total Barrett's eradication: a description of the endoscopic technique, its clinical results and future prospects.
    Pouw RE; Sharma VK; Bergman JJ; Fleischer DE
    Endoscopy; 2008 Dec; 40(12):1033-40. PubMed ID: 19065488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.